Home NDC 13630-0092 Occulus
Product NDC 13630-0092
11-digit product format 136300092
Labeler code 13630
Product ID 13630-0092_9c5c6bcc-c2b7-7c8b-e053-2995a90ad7f0
Type HUMAN OTC DRUG
Nonproprietary name Clotrimazole
Dosage form AEROSOL, FOAM
Route TOPICAL
Labeler Prime Packaging, Inc.
Application part333C
Marketing category OTC MONOGRAPH FINAL
Marketing start 2015-08-01
Marketing end 0000-00-00
Substance CLOTRIMAZOLE
Active strength 10 mg/g
NDC exclude flag No
Listing certified through 2021-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 30 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 13630-0092-3 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 13630-0092-3 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 13630-0092-3 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 13630-0092-3 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 13630-0092-3 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 13630-0092-3 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 13630-0092-3 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 13630-0092-3 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 13630-0092-3 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 13630-0092-3 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 13630-0092-3 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 13630-0092-3 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 excluded product product 8af77b9d5b6f…d9bbb34c5368…2024-05-28 21:12 UTC · source 2024-05-28 excluded package package 13630-0092-3 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 excluded product product 834df4deac94…adcc014656a3…2024-05-15 03:39 UTC · source 2024-05-14 excluded package package 13630-0092-3 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 excluded product product 1332a3947898…d4bfe170f9cd…2024-03-11 06:39 UTC · source 2024-03-08 excluded package package 13630-0092-3 1332a3947898…d4bfe170f9cd…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 13630-0092-3 OcculusSkin Hydrating Topical Foam CLO-1 125 g in 1 CAN AEROSOL, FOAM 125 3
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded CLOTRIMAZOLE ACTIVE INGREDIENT G07GZ97H65 OCCULUS SKIN HYDRATING TOPICAL FOAM CLO-1 (CLOTRIMAZOLE) AEROSOL, FOAM [PRIME PACKAGING, INC.] 1 CLOTRIMAZOLE ACTIVE MOIETY G07GZ97H65 OCCULUS SKIN HYDRATING TOPICAL FOAM CLO-1 (CLOTRIMAZOLE) AEROSOL, FOAM [PRIME PACKAGING, INC.] 1 .ALPHA.-TOCOPHEROL ACETATE INACTIVE INGREDIENT 9E8X80D2L0 OCCULUS SKIN HYDRATING TOPICAL FOAM CLO-1 (CLOTRIMAZOLE) AEROSOL, FOAM [PRIME PACKAGING, INC.] 1 CETEARYL ETHYLHEXANOATE INACTIVE INGREDIENT 9M64UO4C25 OCCULUS SKIN HYDRATING TOPICAL FOAM CLO-1 (CLOTRIMAZOLE) AEROSOL, FOAM [PRIME PACKAGING, INC.] 1 DIMETHICONE INACTIVE INGREDIENT 92RU3N3Y1O OCCULUS SKIN HYDRATING TOPICAL FOAM CLO-1 (CLOTRIMAZOLE) AEROSOL, FOAM [PRIME PACKAGING, INC.] 1 EDETATE DISODIUM INACTIVE INGREDIENT 7FLD91C86K OCCULUS SKIN HYDRATING TOPICAL FOAM CLO-1 (CLOTRIMAZOLE) AEROSOL, FOAM [PRIME PACKAGING, INC.] 1 GLYCERIN INACTIVE INGREDIENT PDC6A3C0OX OCCULUS SKIN HYDRATING TOPICAL FOAM CLO-1 (CLOTRIMAZOLE) AEROSOL, FOAM [PRIME PACKAGING, INC.] 1 PALMITIC ACID INACTIVE INGREDIENT 2V16EO95H1 OCCULUS SKIN HYDRATING TOPICAL FOAM CLO-1 (CLOTRIMAZOLE) AEROSOL, FOAM [PRIME PACKAGING, INC.] 1 POLYSORBATE 20 INACTIVE INGREDIENT 7T1F30V5YH OCCULUS SKIN HYDRATING TOPICAL FOAM CLO-1 (CLOTRIMAZOLE) AEROSOL, FOAM [PRIME PACKAGING, INC.] 1 POVIDONES INACTIVE INGREDIENT FZ989GH94E OCCULUS SKIN HYDRATING TOPICAL FOAM CLO-1 (CLOTRIMAZOLE) AEROSOL, FOAM [PRIME PACKAGING, INC.] 1 PROPYLENE GLYCOL INACTIVE INGREDIENT 6DC9Q167V3 OCCULUS SKIN HYDRATING TOPICAL FOAM CLO-1 (CLOTRIMAZOLE) AEROSOL, FOAM [PRIME PACKAGING, INC.] 1 STEARIC ACID INACTIVE INGREDIENT 4ELV7Z65AP OCCULUS SKIN HYDRATING TOPICAL FOAM CLO-1 (CLOTRIMAZOLE) AEROSOL, FOAM [PRIME PACKAGING, INC.] 1 TROLAMINE INACTIVE INGREDIENT 9O3K93S3TK OCCULUS SKIN HYDRATING TOPICAL FOAM CLO-1 (CLOTRIMAZOLE) AEROSOL, FOAM [PRIME PACKAGING, INC.] 1 UBIDECARENONE INACTIVE INGREDIENT EJ27X76M46 OCCULUS SKIN HYDRATING TOPICAL FOAM CLO-1 (CLOTRIMAZOLE) AEROSOL, FOAM [PRIME PACKAGING, INC.] 1 WATER INACTIVE INGREDIENT 059QF0KO0R OCCULUS SKIN HYDRATING TOPICAL FOAM CLO-1 (CLOTRIMAZOLE) AEROSOL, FOAM [PRIME PACKAGING, INC.] 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 13630-0092 OCCULUS SKIN HYDRATING TOPICAL FOAM CLO-1 (CLOTRIMAZOLE) AEROSOL, FOAM [PRIME PACKAGING, INC.] 3 Legacy NDC, 1 package rows 20200118_33e56295-4edc-43fd-a937-1eeb32414fdb.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 13630-0092-3 13630009203 125 g in 1 CAN (13630-0092-3) 125 g 2015-08-01 0000-00-00 No No Current